Exelixis
EXEL
#1786
Rank
C$13.59 B
Marketcap
$47.62
Share price
-0.09%
Change (1 day)
62.33%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company